Inhibition of miMOMP-induced SASP to combat age-related disease

Xiaoli Liao1, Zhennan Guo1,2, Mouhai He1

  • 1School of Medical Technology and Nursing, Hunan institute of traffic engineering, Hengyang, China.

Frontiers in Aging
|February 13, 2025
PubMed

Insights

Cellular senescence, a state of irreversible cell arrest, is linked to aging and diseases. Understanding its mechanisms is key for developing senotherapy to combat age-related conditions.

Area of Science:

  • Cellular and Molecular Biology
  • Gerontology
  • Biomedical Science

Background:

  • Cellular senescence, identified in 1961, involves normal human fibroblasts ceasing proliferation.
  • This process is triggered by stimuli like oxidative stress and oncogene activation.
  • Senescence is characterized by cell-cycle arrest, apoptosis resistance, and a unique secretory phenotype (SASP).

Purpose of the Study:

  • To elucidate the mechanisms underlying cellular senescence.
  • To explore the link between cellular senescence, aging, and age-related diseases.
  • To inform the development of senotherapy for age-related conditions.

Main Methods:

  • Review of historical and recent research on cellular senescence.
  • Analysis of triggers and characteristics of senescence.
  • Examination of the role of senescence in aging and disease.

Main Results:

  • Cellular senescence is a complex process triggered by various stressors.
  • Senescence is implicated in the aging process and numerous chronic diseases.
  • Targeting senescence (senotherapy) shows promise for age-related disease intervention.

Conclusions:

  • Elucidating senescence mechanisms is crucial for advancing senotherapy.
  • Cellular senescence represents a significant target for therapeutic strategies against aging and related diseases.